These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 12907611)
1. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen. Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611 [TBL] [Abstract][Full Text] [Related]
2. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days. Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927 [TBL] [Abstract][Full Text] [Related]
3. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen. Kim SY; Suzuki N; Laxmi YR; McGarrigle BP; Olson JR; Sharma M; Sharma M; Shibutani S Chem Res Toxicol; 2005 May; 18(5):889-95. PubMed ID: 15892583 [TBL] [Abstract][Full Text] [Related]
4. Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen. Shibutani S; Ravindernath A; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML Carcinogenesis; 2000 Aug; 21(8):1461-7. PubMed ID: 10910945 [TBL] [Abstract][Full Text] [Related]
5. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen. Umemoto A; Monden Y; Lin CX; Abdul-Momen M; Ueyama Y; Komaki K; Laxmi YR; Shibutani S Chem Res Toxicol; 2004 Dec; 17(12):1577-83. PubMed ID: 15606132 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling. Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392 [TBL] [Abstract][Full Text] [Related]
7. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen. Terashima I; Suzuki N; Shibutani S Cancer Res; 1999 May; 59(9):2091-5. PubMed ID: 10232593 [TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-DNA adducts detected in the endometrium of women treated with tamoxifen. Shibutani S; Suzuki N; Terashima I; Sugarman SM; Grollman AP; Pearl ML Chem Res Toxicol; 1999 Jul; 12(7):646-53. PubMed ID: 10409405 [TBL] [Abstract][Full Text] [Related]
9. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide. Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106 [TBL] [Abstract][Full Text] [Related]
10. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans. Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972 [TBL] [Abstract][Full Text] [Related]
11. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice. Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174 [TBL] [Abstract][Full Text] [Related]
12. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods. Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801 [TBL] [Abstract][Full Text] [Related]
13. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus. Li D; Dragan Y; Jordan VC; Wang M; Pitot HC Cancer Res; 1997 Apr; 57(8):1438-41. PubMed ID: 9108442 [TBL] [Abstract][Full Text] [Related]
14. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry. Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436 [TBL] [Abstract][Full Text] [Related]
15. Inefficient repair of tamoxifen-DNA adducts in rats and mice. Kim SY; Suzuki N; Laxmi YR; Shibutani S Drug Metab Dispos; 2006 Feb; 34(2):311-7. PubMed ID: 16299164 [TBL] [Abstract][Full Text] [Related]
16. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen. Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064 [TBL] [Abstract][Full Text] [Related]
17. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment. Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012 [TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-DNA adduct formation in monkey and human reproductive organs. Hernandez-Ramon EE; Sandoval NA; John K; Cline JM; Wood CE; Woodward RA; Poirier MC Carcinogenesis; 2014 May; 35(5):1172-6. PubMed ID: 24501327 [TBL] [Abstract][Full Text] [Related]
20. Mutation spectra induced by alpha-acetoxytamoxifen-DNA adducts in human DNA repair proficient and deficient (xeroderma pigmentosum complementation group A) cells. McLuckie KI; Crookston RJ; Gaskell M; Farmer PB; Routledge MN; Martin EA; Brown K Biochemistry; 2005 Jun; 44(22):8198-205. PubMed ID: 15924439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]